Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles

被引:99
作者
Gong, Jian [1 ]
Huo, Meirong [1 ]
Zhou, Jianping [1 ]
Zhang, Yong [1 ]
Peng, Xiaoling [1 ]
Yu, Di [1 ]
Zhang, Hui [1 ]
Li, Jing [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut, Nanjing 210009, Peoples R China
关键词
Octyl modified serum albumin (OSA); Polymeric micelles; Paclitaxel; Drug-loading; Hemolysis; Cytotoxicity; CREMOPHOR-FREE; PACLITAXEL DELIVERY; POLYMERIC MICELLES; PHASE-I; FORMULATION; PROTEIN; TAXOL; NANOPARTICLES; DERIVATIVES; EFFICACY;
D O I
10.1016/j.ijpharm.2009.04.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A novel albumin derivative octyl modified serum albumin (OSA) which can form a core-shell structure in aqueous media by self-assembling due to core segregation and a combination of intermolecular forces has been synthesized. The chemical structure and physical properties of OSA were characterized by FTIR, H-1 NMR and TG. The degree of substitution (DS) was in the range of 52.4-69.7% and 48.9-65.8% determined by elemental analysis and fluorescamine assay, respectively. With the increase in the DS of octyl group, the critical micelle concentration (CMC) decreased from 30.1 to 14.7 mg/L because of the increasing hydrophobicity. In the light of the hydrophobic core as a microreservoir for poorly water-soluble drugs, paclitaxel (M) was successfully loaded into OSA micelles by the dialysis method with a high drug-loading (33.1 wt%) and entrapment efficiency (90.5%) due to the synergistic effect of micellar encapsulation and binding interaction between drug and OSA. Compared with PTX-loaded unmodified BSA preparation, PTX-loaded OSA micelles are characterized by small size, narrow size distribution, great drug-loading capacity and enhanced stability. The size of M-loaded micelles was in the range of 123.3-152.8 nm and smaller than their corresponding blank micelles. Hemolysis and cytotoxicity studies showed that OSA was safer than Tween-80 and Cremophor EL as an injectable pharmaceutic adjuvant for M. In terms of the greater drug-loading capacity and safer character, the novel albumin derivative OSA is a prospective injectable delivery system for M. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 36 条
[1]  
Aliabadi Hamidreza Montazeri, 2006, Expert Opin Drug Deliv, V3, P139
[2]   Safety and efficacy of amphiphilic β-cyclodextrin nanoparticles for paclitaxel delivery [J].
Bilensoy, Erem ;
Gurkaynak, Oya ;
Dogan, A. Lale ;
Hincal, A. Atilla .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 347 (1-2) :163-170
[3]   In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC [J].
Bouquet, W. ;
Boterberg, T. ;
Ceelen, W. ;
Pattyn, P. ;
Peeters, M. ;
Bracke, M. ;
Remon, J. P. ;
Vervaet, C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 367 (1-2) :148-154
[4]  
CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
[5]  
Chemmanur AT, 2006, CURR OPIN INVEST DR, V7, P750
[6]  
Fang J, 2003, ADV EXP MED BIOL, V519, P29
[7]  
FIGGE J, 1991, J LAB CLIN MED, V117, P453
[8]   Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation [J].
Gelderblom, H ;
Verweij, J ;
Nooter, K ;
Sparreboom, A .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) :1590-1598
[9]   Structural basis of the drug-binding specificity of human serum albumin [J].
Ghuman, J ;
Zunszain, PA ;
Petitpas, I ;
Bhattacharya, AA ;
Otagiri, M ;
Curry, S .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 353 (01) :38-52
[10]   An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile [J].
He, L ;
Wang, GL ;
Zhang, Q .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (01) :45-50